Alto支架移植物在希腊注册研究中一年结果
BACKGROUND: The Alto endograft received CE Mark approval in August 2020 for endovascular repair of abdominal aortic aneurysms (AAAs), requiring a proximal aortic landing zone of only 7 mm below the inferior renal artery for sealing.…
要点
- Alto支架近端锚定区仅需肾下7 mm,适用于短颈等挑战性解剖。
核心结论
- Alto支架在真实世界实践中显示优异的技术和临床成功率,1年再干预率低,包括部分近端和远端解剖挑战性患者。
研究设计与样本
- 希腊多中心前瞻性数据库,纳入2021至2023年接受Alto腹主动脉支架系统EVAR的124例完整腹主动脉瘤患者(择期或症状性急诊)。
- 患者96%为男性,平均年龄72.1±6岁,平均AAA直径59.8±10 mm,94%无症状。
主要发现
- 技术成功率98%,2例术中转为主-单髂支架加股-股旁路,6例接受分支支架内衬。
- 平均手术时间129±60 min,平均对比剂用量130±50 mL,中位辐射时间27±18 min,平均住院2.5±1.5天。
- 30天无死亡或再干预,无术中高流量内漏。
- 30天和1年瘤囊平均直径分别为58±11 mm和53.6±8 mm,1年时58%稳定、34%缩小。
关键数值与推荐
- 近端锚定区仅需肾下7 mm,该处平均颈直径23±3 mm、长度18±9 mm、成角28±14°。
临床怎么用
- Alto支架可用于近端锚定区短至7 mm及远端解剖挑战的AAA患者,短期再干预率低。
- 术后1年需关注瘤囊 remodeling 和内漏,尽管免于I型内漏率较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Alto endograft received CE Mark approval in August 2020 for endovascular repair of abdominal aortic aneurysms (AAAs), requiring a proximal aortic landing zone of only 7 mm below the inferior renal artery for sealing. This study presents early and 1-year outcomes from the Hellenic Alto Registry in patients treated for intact AAAs, either electively or urgently for symptomatic aneurysms. METHODS: The Hellenic Registry is a multicenter prospective database including patients who underwent endovascular aneurysm repair with the Alto Abdominal Stent Graft System between 2021 and 2023. Preoperative and postoperative aneurysm characteristics were recorded. Outcomes included early (technical success, 30-day survival) and 1-year results (survival, reintervention, sac remodeling, and endoleak presence). RESULTS: A total of 124 patients (96% male, mean age 72.1 ± 6, mean AAA diameter 59.8 ± 10 mm) were included; 94% were asymptomatic. Mean proximal neck diameter at 7 mm was 23 ± 3 mm, length 18 ± 9 mm, and angulation 28 ± 14°. Nineteen patients (15%) had neck length <10 mm, and 14 (11%) had an aortic bifurcation <20 mm. Fifty-eight (45%) had at least 1 external iliac artery <7 mm. Technical success was 98%; 2 patients required intraoperative conversion to an aorto-uni-iliac endograft with femorofemoral bypass. Six patients underwent limb relining. Mean procedure time was 129 ± 60 min, mean contrast volume was 130 ± 50 mL, and median radiation 27 ± 18 min. Mean hospital stay was 2.5 ± 1.5 days. No intraoperative high flow endoleaks were detected. No death of reintervention was reported at 30 days. The mean aneurysm sac diameter was 58 ± 11 mm and 53.6±8 mm at 30 days and 1 postoperative year (58% stable, 34% decreased), respectively. At 1-year follow-up, the survival rate was 99,2% [standard error (SE) 0,8%], 98,4% (SE 1,1%) and 98,4% (SE 1,1%) at 80, 120 and 365 days respectively; The freedom from reintervention rate was rate was 99,2% (SE 0,8%), 98,4% (SE 1,1%), 96,7% (SE 1,6%) and 95,9% (SE 1,8%) at 30, 60, 180 and 365 days respectively. Freedom from type I endoleak rate was 99,2% (0,8%), 98,4% (SE 1,1%) and 97,5% (SE 1,4%) at 30, 180 and 365 days respectively. CONCLUSION: In real-world practice, the Alto stent graft demonstrated excellent technical and clinical success with low reintervention rates at 1 year, including a part of patients with challenging proximal and distal anatomy.
引用
- Barbatis A, Spanos K, Ioannou C, et al. One Year Outcomes of Endovascular Aneurysm Repair with the Alto Stent Graft in the Hellenic Alto Registry. Ann Vasc Surg. 2026. PMID: 41651164. doi:10.1016/j.avsg.2026.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。